A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

Clinical trial NCT06006793 · UNKNOWN

Trial details

NCT number: NCT06006793
Sponsor: Shouyao Holdings (Beijing) Co. LTD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-08-10
Primary completion: 2025-02-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.